Literature DB >> 21911043

Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy.

Hu-Lin Jiang1, Seong-Ho Hong, You-Kyoung Kim, Mohammad Ariful Islam, Hye-Joon Kim, Yun-Jaie Choi, Jae-Woon Nah, Kee-Ho Lee, Ki-Won Han, Chanhee Chae, Chong-Su Cho, Myung-Haing Cho.   

Abstract

Polyethylenimine (PEI) has been commonly used as a cationic polymeric gene carrier due to high transfection efficiency, however, its cytotoxicity has hindered the practical application. In this study, we report the development of poly(amino ester) (PAE) based on glycerol propoxylate triacrylate (GPT) and spermine (SPE) as an alternative gene carrier for lung cancer therapy. GPT-SPE copolymer was prepared by Michael addition reaction between GPT and SPE, and the efficacy was evaluated using shAkt1 as a model therapeutic gene. The molecular weight and composition were characterized using gel permeability chromatography (GPC) and (1)H-nuclear magnetic resonance ((1)H-NMR), respectively. The GPT-SPE could effectively condense DNA with about 163 nm size and protect the DNA from nucleases. GPT-SPE/DNA complexes showed excellent transfection with low toxicity both in vitro and in vivo. Furthermore, aerosol delivery of GPT-SPE/Akt1 shRNA complexes significantly suppressed lung tumorigenesis in K-ras(LA1) lung cancer model mice. These results suggest that GPT-SPE can be used in shRNA-based lung cancer gene therapy.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911043     DOI: 10.1016/j.ijpharm.2011.08.045

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  GOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapy.

Authors:  Seung-Hee Chang; Seong-Ho Hong; Hu-Lin Jiang; Arash Minai-Tehrani; Kyeong-Nam Yu; Jae-Ho Lee; Ji-Eun Kim; Ji-Young Shin; Bitna Kang; Sungjin Park; Kiwon Han; Chanhee Chae; Myung-Haing Cho
Journal:  Mol Ther       Date:  2012-06-26       Impact factor: 11.454

Review 2.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

3.  Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.

Authors:  Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2012-09-22

Review 4.  Development of small RNA delivery systems for lung cancer therapy.

Authors:  Yu Fujita; Kazuyoshi Kuwano; Takahiro Ochiya
Journal:  Int J Mol Sci       Date:  2015-03-06       Impact factor: 5.923

Review 5.  A bumpy and winding but right path to domestic drug-eluting coronary stents.

Authors:  Jae Yeong Cho; Youngkeun Ahn; Myung Ho Jeong
Journal:  Korean Circ J       Date:  2013-10       Impact factor: 3.243

6.  Folate-conjugated polyspermine for lung cancer-targeted gene therapy.

Authors:  Mei Zhang; You-Kyoung Kim; Pengfei Cui; Jialiang Zhang; Jianbin Qiao; Yujing He; Jinyuan Lyu; Chengqiong Luo; Lei Xing; Hulin Jiang
Journal:  Acta Pharm Sin B       Date:  2016-04-12       Impact factor: 11.413

7.  Influence of oligospermines architecture on their suitability for siRNA delivery.

Authors:  Maha Elsayed; Vincent Corrand; Vidula Kolhatkar; Yuran Xie; Na Hyung Kim; Rohit Kolhatkar; Olivia M Merkel
Journal:  Biomacromolecules       Date:  2014-03-04       Impact factor: 6.988

Review 8.  Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.

Authors:  Rui-Xing Yin; De-Zhai Yang; Jin-Zhen Wu
Journal:  Theranostics       Date:  2014-01-08       Impact factor: 11.556

Review 9.  Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery.

Authors:  Ji Young Yhee; Jintaek Im; Richard Seonghun Nho
Journal:  J Clin Med       Date:  2016-09-20       Impact factor: 4.241

Review 10.  Drug- and Gene-eluting Stents for Preventing Coronary Restenosis.

Authors:  Kamali Manickavasagam Lekshmi; Hui-Lian Che; Chong-Su Cho; In-Kyu Park
Journal:  Chonnam Med J       Date:  2017-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.